Intranasal delivery bypasses the blood-brain barrier to target therapeutics to the brain to improve memory in humans with Alzheimer's and treat neurodegenerative disorders in animal models [presentation]
Presentation
Overview
occurs within event
GTCbio Therapeutic Strategies Against Neurodegenerative Conditions
Research
keywords
Alzheimer's Disease
Animal Studies
Blood
Brain
Drugs and Drug Therapy
Intranasal Administration
